Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Weissmann

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]W Janssen, H A Ghofrani, N Weissmann, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
The role of classical transient receptor potential channels in the regulation of hypoxic pulmonary vasoconstrictionB Fuchs, A Dietrich, T Gudermann, et al.
The Journal of Antibiotics|July 1, 1987
Deoxyspergualin, a potent antitumor agent: further studies on the cytobiological mode of actionW E Müller, N Weissmann, A Maidhof, et al.
Deutsche Medizinische Wochenschrift (1946)|April 21, 2006
[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension]H A Ghofrani, R T Schermuly, N Weissmann, et al.
The American Journal of Physiology|May 1, 1995
Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungsF Grimminger, N Weissmann, R Spriestersbach, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2015
Time course of cigarette smoke-induced changes of systemic inflammation and muscle structureK Krüger, G Dischereit, M Seimetz, et al.
European Journal of Clinical Investigation|April 2, 2009
The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studiesN J Davie, R T Schermuly, N Weissmann, et al.
The Journal of Antibiotics|June 1, 1985
Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytesN Weissmann, G Leyhausen, A Maidhof, et al.
The Journal of Laboratory and Clinical Medicine|December 26, 2001
Physiologic basis for the treatment of pulmonary hypertensionH Olschewski, A Olschewski, F Rose, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injuryR T Schermuly, A Günther, N Weissmann, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]W Janssen, H A Ghofrani, N Weissmann, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
The role of classical transient receptor potential channels in the regulation of hypoxic pulmonary vasoconstrictionB Fuchs, A Dietrich, T Gudermann, et al.
The Journal of Antibiotics|July 1, 1987
Deoxyspergualin, a potent antitumor agent: further studies on the cytobiological mode of actionW E Müller, N Weissmann, A Maidhof, et al.
Deutsche Medizinische Wochenschrift (1946)|April 21, 2006
[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension]H A Ghofrani, R T Schermuly, N Weissmann, et al.
The American Journal of Physiology|May 1, 1995
Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungsF Grimminger, N Weissmann, R Spriestersbach, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2015
Time course of cigarette smoke-induced changes of systemic inflammation and muscle structureK Krüger, G Dischereit, M Seimetz, et al.
European Journal of Clinical Investigation|April 2, 2009
The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studiesN J Davie, R T Schermuly, N Weissmann, et al.
The Journal of Antibiotics|June 1, 1985
Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytesN Weissmann, G Leyhausen, A Maidhof, et al.
The Journal of Laboratory and Clinical Medicine|December 26, 2001
Physiologic basis for the treatment of pulmonary hypertensionH Olschewski, A Olschewski, F Rose, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injuryR T Schermuly, A Günther, N Weissmann, et al.
Pageof 7